The role of the biochemical features of the SARS-CoV-2 spike protein in human transmission

In a recent study posted to the bioRxiv* preprint server, researchers evaluated all biochemical changes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein to explore their evolutionary significance.

Study: Evolution to increased positive charge on the viral spike protein may be part of the adaptation of SARS-CoV-2 to human transmission. Image Credit: creativeneko/Shutterstock
Study: Evolution to increased positive charge on the viral spike protein may be part of the adaptation of SARS-CoV-2 to human transmission. Image Credit: creativeneko/Shutterstock

*Important notice: bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Background

The S protein dominates the exterior surface of the SARS-CoV-2, hence had to change itself physically and biochemically the most to avoid immune recognition. In addition, there is a possibility that the second level of selective pressure acts on the S protein to help SARS-CoV-2 evolve and adjust to the physical transmission between humans.

Over the course of the coronavirus disease 2019 (COVID-19) pandemic, SARS-CoV-2 S protein has evolved from a protein with a total charge of -8.28 to -1.26 in the original lineages A and B, and the most recent Omicron variant of concern (VOC), respectively. Two previous studies by Pawłowski in 2021 and Nie et al. in 2022 had noted this pattern.

About the study

In the present study, researchers used over 11 million SARS-CoV-2 genomic sequences retrieved up to June 15, 2022, to monitor changes in the S protein, including its charge, size, hydrophobicity, and folding over two years of SARS-CoV-2 evolution. They performed a principal component analysis (PCA) to identify the physical features of S most strongly linked with SARS-CoV-2 lineages linked to genomic surveillance data.

The team extracted intact S protein sequences and collected them into a matrix. They also investigated changes in charge of S protein throughout the pandemic and plotted the total S charge for all genomes per month of the pandemic. Furthermore, the researchers retrieved the S coding region of all available coronavirus (CoV) 229E full genomes sequences from GenBank.

Study findings

The PCA identified eight top features, including charge, gravy, fraction T, R, D, K, and G, and instability clustered SARS-CoV-2 S sequences by lineage. The results also highlighted the S protein charge as the key determinant of all the SARS-CoV-2 lineages that evolved during the first two years of the COVID-19 pandemic.

The results showed a clear pattern of increase in S charge over two years of SARS-CoV-2 evolution, with the first surge between early 2020 and March 2020. During this time, the researchers noted an increase in positive charge to -7.28. Subsequently, they observed an additional increase of -3.28 in positive charge in mid-2021. The last round of increase in S positive charge in early 2021 brought it to around -1.26. The study results pointed to each round of increase in positive charge of S protein to the major SARS-CoV-2 lineages reported over time. For instance, the majority of Omicron sub-variants showed S protein positive charge increases of around -1.3.

The location of the substitutions in the S protein indicated the functional consequences of the observed changes in the S charge. The authors noted an initial change in S charge was associated with the substitution of an aspartic acid residue (D, -1) with a glycine (G, neutral) relative to the initial Lineage B genome sequences. While the Delta lineage S encoded additional positive charge in the angiotensin-converting enzyme 2 (ACE2) binding region and heptad repeat (HR1) region, Omicron S showed a predominance of positive charge changes in the receptor-binding domain (RBD).

Comparing 229E CoVs infecting camels and humans revealed a difference of almost nine charge units in S median charge. However, they observed no difference in S charge for the Middle East Respiratory Syndrome coronavirus (MERS-CoV) infecting humans and camels.

Conclusions

The current study highlighted how by increasing the positive charge on its S, SARS-CoV-2 interacts with the negatively charged matrix of mucins in the human upper respiratory tract and promotes binding and transmission inside the host cells. Since MERS-CoV has not made similar changes in the S charge, its human transmission chains end after two to three transmission events.

The study also evidenced that the broad location of the positive changes across the S protein sequences of OC43, 229E, and SARS-CoV-2 might be responsible for receptor binding, furin cleavage, cell fusion, and antigenic changes that help avoid or promote ionic interactions during human to human transmission. However, due to functional constraints, the SARS-CoV-2 S protein will eventually settle at an upper limit of charge. Perhaps this is why all Omicron sublineages, after more than six months of evolution, have now settled into the range of S charge of around -1.

To summarize, the study provides a much-needed framework to monitor CoV evolution through changes in biochemical properties of their S proteins. This data could help trace other viruses threatening public health globally. Additionally, the study findings could help predict the timing of the emergence of new SARS-CoV-2 variants based on more positively charged changes in S protein.

*Important notice: bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Neha Mathur

Written by

Neha Mathur

Neha is a digital marketing professional based in Gurugram, India. She has a Master’s degree from the University of Rajasthan with a specialization in Biotechnology in 2008. She has experience in pre-clinical research as part of her research project in The Department of Toxicology at the prestigious Central Drug Research Institute (CDRI), Lucknow, India. She also holds a certification in C++ programming.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mathur, Neha. (2022, August 03). The role of the biochemical features of the SARS-CoV-2 spike protein in human transmission. News-Medical. Retrieved on November 25, 2024 from https://www.news-medical.net/news/20220803/The-role-of-the-biochemical-features-of-the-SARS-CoV-2-spike-protein-in-human-transmission.aspx.

  • MLA

    Mathur, Neha. "The role of the biochemical features of the SARS-CoV-2 spike protein in human transmission". News-Medical. 25 November 2024. <https://www.news-medical.net/news/20220803/The-role-of-the-biochemical-features-of-the-SARS-CoV-2-spike-protein-in-human-transmission.aspx>.

  • Chicago

    Mathur, Neha. "The role of the biochemical features of the SARS-CoV-2 spike protein in human transmission". News-Medical. https://www.news-medical.net/news/20220803/The-role-of-the-biochemical-features-of-the-SARS-CoV-2-spike-protein-in-human-transmission.aspx. (accessed November 25, 2024).

  • Harvard

    Mathur, Neha. 2022. The role of the biochemical features of the SARS-CoV-2 spike protein in human transmission. News-Medical, viewed 25 November 2024, https://www.news-medical.net/news/20220803/The-role-of-the-biochemical-features-of-the-SARS-CoV-2-spike-protein-in-human-transmission.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients